General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a dermatitis imageMay 22 2018

‘Scratch Beneath the Surface’, a new UK public health initiative intended to improve people’s understanding of atopic dermatitis, has been launched online.

Created by Sanofi UK in collaboration with national charity Allergy UK, the initiative is designed to help people gain a better understanding about what’s happening inside the body, as well as the emotional and psychological symptoms that can lie beneath the surface.

A UK-wide survey of people with moderate-to-severe atopic dermatitis found that the disease can impact every aspect of an individual’s life, said Sanofi. Difficulty sleeping affected 75% of those surveyed, with the constant itching and pain when trying to sleep leaving people feeling tired and restless in the day.

Respondents also highlighted the impact it has on mental wellbeing:

  • 80% of survey participants reported that atopic dermatitis has a direct impact on their mood;
  • 57% admitted they feel depressed because of their skin with some taking antidepressants to try and help the situation;
  • 60% of male participants and 55% of female participants noted that their self-esteem and self-confidence is frequently impacted due to their skin condition;
  • 56% reported finding it hard to be intimate with their partner when their skin is bad.

“Atopic dermatitis is often dismissed as a simple skin condition or rash that can be soothed with moisturisers, but people don’t realise that it’s a long-term and potentially life-altering disease,” said Carla Jones, Allergy UK’s Chief Executive. 

“There is a huge sense of frustration amongst those affected, who feel that eczema and atopic dermatitis are often misunderstood. Even simple day-to-day tasks like walking up the stairs, bathing and getting dressed can be painful for someone experiencing a flare-up.”

Dr Jasmin Hussein, Head of Immunology – Dermatology & Respiratory at Sanofi UK & Ireland, added: “Diseases like atopic dermatitis are often trivialised and seen as ‘just a skin problem’, thus the real-life burden is not always recognised.

“This is why Scratch Beneath the Surface has been developed – to increase understanding towards those living with atopic dermatitis and raise awareness of the reality of this sometimes life long, life changing disease.”

Links:
Sanofi UK announcement         
Scratch Beneath the Surface website      
Allergy UK         

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...